Stock Events

Stock Events

Search...

Inari Medical

$53.84

39

-$1.36-2.46% Today

Statistics

Day High

-

Day Low

53.75

52W High

71.85

52W Low

36.73

Volume

1,048,601

Avg. Volume

787,230

Mkt Cap

3.13B

P/E Ratio

-131.22

Dividend Yield

-

Dividend

-

Earnings

30AprConfirmed

Q3 2022

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

-0.33

-0.2

-0.08

0.05

Expected EPS

-0.2

Actual EPS

-0.33

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NARI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Penumbra directly competes with Inari Medical in the market for devices used in thrombectomy and embolization procedures, particularly in treating pulmonary embolism and deep vein thrombosis.

Boston Scientific

Boston Scientific competes with Inari Medical through its interventional cardiology and peripheral interventions products, including devices for vascular embolization and thrombectomy.

Abbott Laboratories

Abbott Laboratories offers a range of vascular devices, competing in areas overlapping with Inari Medical's focus, especially in treatments involving catheter-based procedures.

Medtronic competes with Inari Medical in the broader market for medical devices used in endovascular therapies, including products for the treatment of venous diseases.

Johnson & Johnson

Johnson & Johnson, through its medical device segment, competes in the vascular surgery and interventional radiology sectors, areas relevant to Inari Medical's product offerings.

Sanara MedTech offers products in wound and skin care that can be adjunctive to the vascular treatments Inari Medical focuses on, positioning them as indirect competitors.

AngioDynamics produces medical, surgical, and diagnostic devices that compete with Inari Medical's offerings, especially in the venous disease treatment market.

ICU Medical competes with Inari Medical in the critical care space, offering products that can be used in conjunction with or as alternatives to Inari's devices in vascular access and therapy.

Baxter International

Baxter International competes in the broader healthcare and medical device market, with products that can intersect with the care pathways Inari Medical's devices are used in.

Zimmer Biomet, primarily known for orthopedic devices, has expanded into areas that can compete with Inari Medical, especially in the surgical and post-surgical care sectors.

Analyst Ratings

62.25$Average Price Target

The highest estimate is $84.

From 6 ratings within the last 6 months. This is not an investment recommendation.

Buy

50%

Hold

50%

Sell

0%

About

Health Technology

Medical Specialties

Manufacturing

Surgical and Medical Instrument Manufacturing

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Show more...

CEO

Employees

1300

Country

US

ISIN

US45332Y1091

WKN

000A2P41U

Listings